Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cogent Biosciences, Inc.

6.80
+0.810013.52%
Post-market: 7.000.2000+2.94%16:52 EDT
Volume:2.72M
Turnover:18.38M
Market Cap:774.75M
PE:-3.34
High:6.99
Open:6.11
Low:6.11
Close:5.99
Loading ...
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 12, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 06, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 17, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 16, 2022

Major Issues Report

8-K/A [Amend] - Current report
Jun 15, 2022

Major Issues Report

8-K - Current report
Jun 14, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 10, 2022

Major Issues Report

8-K - Current report
May 20, 2022

Correspondence

CORRESP [Cover] - Correspondence
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2022

Major Issues Report

8-K - Current report
May 06, 2022

Major Issues Report

8-K - Current report